ArrePath

ArrePath is a biotechnology company focused on discovering new anti-infectives to combat antimicrobial resistance. They utilize AI/ML platforms to identify novel small molecules with unique mechanisms of action, targeting multidrug-resistant infections. Their lead program is advancing towards investigational new drug (IND)-enabling studies for complicated urinary tract infections.

Buy Funded Startups lists

Funding Round: Grant

Funding Amount: £1M

Date: 19-Nov-2024

Investors: PACE (Pathways to Antimicrobial Clinical Efﬁcacy)

Markets: Biotechnology, Pharmaceuticals, AI, Machine Learning, Medical, Health Care

HQ: Princeton, New Jersey, United States

Founded: 2022

Website: https://arrepath.com/

LinkedIn: https://www.linkedin.com/company/arrepath

Twitter:

Instagram: